Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Avivagen Inc V.VIV.H

Alternate Symbol(s):  VIVXF

Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a proprietary product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia. It offers OxC-beta to approximately 46.6 million food animals (poultry, swine, and dairy cattle), 133,820 dogs and 4,000 people.


TSXV:VIV.H - Post by User

Bullboard Posts
Post by drilltip1on Apr 04, 2012 8:06am
287 Views
Post# 19756982

For the future

For the future

This is the kind of product that once it's adopted as the alternative to antibiotics the share price will go up. That being said it's going to take time, we have to convince the large scale animal farmers to dump the antibiotics and use the CFR product that kind of mentallity change will take time. Would be nice to see some heavy volume at these low levels. I'm very surprised that the accumulation has stopped especially at these very low levels, news will help this. Shoud get some of that news soon is a logical guess. Great product that the population would like but schooling them in the benifits of it is a long term thing.

 

Can't go much lower, maybe the year end report that is due by the end of the month will shed some light. There revenues were climbing and I hope the Q4 report shows the same. If we are a take over target I imagine a 400 % premium would do the trick and that in it's self would be a steal for the new owner.

Bullboard Posts